Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/12/2000 | US6159477 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
12/12/2000 | US6159467 In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy |
12/12/2000 | US6159463 Lymphocyte chemoattractant factor |
12/12/2000 | US6159368 Multi-well microfiltration apparatus |
12/12/2000 | US6159270 Phytoremediation of metals |
12/12/2000 | CA2222592C Improved methods of producing feed by reducing endogenous protein levels in soybean |
12/12/2000 | CA2014948C Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity |
12/12/2000 | CA1341153C Hybrid bacillus thuringiensis gene, plasmid, and transformed pseudomonas fluorescens |
12/12/2000 | CA1341152C Receptor protein for human b cell stimulatory factor-2 |
12/11/2000 | CA2272793A1 Porcine transmissible gastroenteritis virus oral vaccine production in plants |
12/11/2000 | CA2272788A1 Means and methods for transformation of plant mitochondria |
12/09/2000 | CA2308691A1 Live attenuated bacteria for use in a vaccine |
12/09/2000 | CA2307933A1 Replicating or semi-replicating viral constructs, preparation and uses for gene delivery |
12/07/2000 | WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor |
12/07/2000 | WO2000073796A2 Ligand-anchor conjugates for producing a biosensor layer |
12/07/2000 | WO2000073791A1 Remedies for kidney diseases and method for screening the same |
12/07/2000 | WO2000073788A1 Use of gabapentin in assays to identify gabab receptor modulators |
12/07/2000 | WO2000073766A1 Genetic assay system |
12/07/2000 | WO2000073764A2 Composition and methods for the therapeutic use of an atonal-associated sequence |
12/07/2000 | WO2000073511A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
12/07/2000 | WO2000073510A1 iETHOD OF TRANSPOSON-MEDIATED MUTAGENESIS IN THE NEMATODE CAENORHABDITIS ELEGANS |
12/07/2000 | WO2000073508A1 Methods and compositions for isolating high molecular weight dna from natural samples |
12/07/2000 | WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
12/07/2000 | WO2000073504A2 Microarray chip and method for indexing the same |
12/07/2000 | WO2000073501A2 Nucleic acid molecules with specific identification of native prpsc, their production and the use thereof |
12/07/2000 | WO2000073499A2 Nucleic acid probes and methods for detecting clinically important fungal pathogens |
12/07/2000 | WO2000073487A1 Novel viral vectors having enhanced effectiveness with dramatically reduced virulence |
12/07/2000 | WO2000073484A1 A global regulator used to enhance the synthesis of aromatic substances |
12/07/2000 | WO2000073482A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
12/07/2000 | WO2000073481A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders |
12/07/2000 | WO2000073480A1 Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus |
12/07/2000 | WO2000073479A1 A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector |
12/07/2000 | WO2000073478A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
12/07/2000 | WO2000073477A1 Methods for induction of tolerance to adenoviral vectors and transgene products |
12/07/2000 | WO2000073476A1 Vector for integration of heterologous sequences into poxviral genomes |
12/07/2000 | WO2000073475A1 Methods for modulating water-use efficiency or productivity in a plant |
12/07/2000 | WO2000073474A1 Maize rs81 promoter and methods of use thereof |
12/07/2000 | WO2000073473A1 Method for reducing phytate in canola meal using genetic manipulation involving myo-inositol 1-phosphate synthase gene |
12/07/2000 | WO2000073472A1 Vector containing polysaccharide degrading enzyme gene as a selection marker, host transformed therewith, method for selecting transformant, medium for selecting the transformant and method of producing medium thereof |
12/07/2000 | WO2000073471A1 Cationic lipids for gene transfer and preparation method thereof |
12/07/2000 | WO2000073470A2 Endo- and exo-glucanase polynucleotides and methods of use |
12/07/2000 | WO2000073469A2 Protein kinases |
12/07/2000 | WO2000073468A1 Novel murine and human kinases |
12/07/2000 | WO2000073466A1 Novel gbv sequence |
12/07/2000 | WO2000073465A1 Peptides capable of inducing hiv-specific ctl and preventives/remedies for aids containing the peptides |
12/07/2000 | WO2000073464A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy |
12/07/2000 | WO2000073463A1 Groel muteins with improved stability |
12/07/2000 | WO2000073462A2 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
12/07/2000 | WO2000073461A1 Methods and gene products for altering the shape of cells and organs in plants |
12/07/2000 | WO2000073460A2 Modified cytokine for its stabilisation |
12/07/2000 | WO2000073459A1 Four-helical bundle protein zsig81 |
12/07/2000 | WO2000073458A1 Secreted alpha-helical protein-31 |
12/07/2000 | WO2000073457A1 Mammalian interleukin-10 homologs: il-d110 and il-d210 |
12/07/2000 | WO2000073456A1 A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY |
12/07/2000 | WO2000073455A1 Biosynthesis of foreign proteins using transformed microalgae |
12/07/2000 | WO2000073454A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/07/2000 | WO2000073453A1 T-bet compositions and methods of use thereof |
12/07/2000 | WO2000073452A2 Compositions and methods for the treatment of immune related diseases |
12/07/2000 | WO2000073451A1 Mammalian receptor proteins; related reagents and methods |
12/07/2000 | WO2000073450A2 Cytoskeleton-associated proteins |
12/07/2000 | WO2000073449A1 Dna encoding snorf33 receptor |
12/07/2000 | WO2000073448A1 Adipocyte complement related protein homolog zacrp7 |
12/07/2000 | WO2000073447A1 RinTinTin, A CHEMOKINE |
12/07/2000 | WO2000073446A2 Adipocyte complement related protein homolog zacrp6 |
12/07/2000 | WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3) |
12/07/2000 | WO2000073444A1 Adipocyte complement related protein homolog zacrp5 |
12/07/2000 | WO2000073443A1 Lipid metabolism transcription factor |
12/07/2000 | WO2000073442A1 Novel cytokine |
12/07/2000 | WO2000073441A1 GENE Any-RF, DORMANCY REGULATORY SUBSTANCE, PROCESS FOR PRODUCING THE SAME AND CELL REGULATOR FOR VITAL CELLS |
12/07/2000 | WO2000073440A1 Pollinosis-associated gene 787 |
12/07/2000 | WO2000073439A1 Pollinosis-associated gene 465 |
12/07/2000 | WO2000073438A1 Tumor-associated antigen (c42) |
12/07/2000 | WO2000073437A1 Assays for caspase activity using green fluorescent proteins |
12/07/2000 | WO2000073436A1 Oligonucleotide for detection and identification of mycobacteria |
12/07/2000 | WO2000073434A1 Gene switches |
12/07/2000 | WO2000073433A1 Screening method for peptides |
12/07/2000 | WO2000073431A2 Methods and compositions for measuring ion channel conductance |
12/07/2000 | WO2000073430A2 Vaccines against conformation-dependent antigens and against antigens that are not or are not only proteins or peptides |
12/07/2000 | WO2000073428A1 Novel endo-beta-1,4-glucanases |
12/07/2000 | WO2000073424A1 A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors |
12/07/2000 | WO2000073423A1 Packaging cell |
12/07/2000 | WO2000073422A1 Genetically modified plant cells and plants with an increased activity of an amylosucrase protein and a branching enzyme |
12/07/2000 | WO2000073416A1 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
12/07/2000 | WO2000073415A2 A method for the transfer of antigens to dendritic cells |
12/07/2000 | WO2000073414A1 Bacteria transformation kit |
12/07/2000 | WO2000073349A1 Dr4 antibodies and uses thereof |
12/07/2000 | WO2000073348A2 Methods and compositions for inhibiting neoplastic cell growth |
12/07/2000 | WO2000073346A1 Immunoconjugates having high binding affinity |
12/07/2000 | WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
12/07/2000 | WO2000073342A1 Structural models for cytoplasmic domains of transmembrane receptors |
12/07/2000 | WO2000073340A1 C-cam as an angiogenesis inhibitor |
12/07/2000 | WO2000073339A1 NOVEL INTEGRIN αSUBUNIT AND USES THEREOF |
12/07/2000 | WO2000073338A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
12/07/2000 | WO2000073337A1 Polymer conjugates of hedgehog proteins and uses |
12/07/2000 | WO2000073336A1 Fimbrial proteins |
12/07/2000 | WO2000073335A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
12/07/2000 | WO2000073334A2 Human sorting nexins |
12/07/2000 | WO2000073328A2 Unc-5 constructs and screening methods |
12/07/2000 | WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation |
12/07/2000 | WO2000073323A2 Adam polynucleotides and polypeptides |